Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy

BACKGROUND. The objective of this study was to characterize the clinicopathologic features of sicca syndrome associated with immune checkpoint inhibitor (ICI) therapy. SUBJECTS, MATERIALS, AND METHODS. Consecutive patients with new or worsening xerostomia in the setting of ICI treatment for benign o...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncologist
Prif Awduron: Warner, Blake M., Baer, Alan N., Lipson, Evan J., Allen, Clint, Hinrichs, Christian, Rajan, Arun, Pelayo, Eileen, Beach, Margaret, Gulley, James L., Madan, Ravi A., Feliciano, Josephine, Grisius, Margaret, Long, Lauren, Powers, Astin, Kleiner, David E., Cappelli, Laura, Alevizos, Ilias
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons, Inc. 2019
Pynciau:
Immuno‐Oncology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6738284/
https://ncbi.nlm.nih.gov/pubmed/30996010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0823
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg